In a marriage of two companies operating out of Volta, Blue Charm Adherence has purchased Symbi Medical for an undisclosed price to increase the capabilities of its software and help patients get the best treatment possible.
Blue Charm is led by CEO Greg Patey, previously one of the Co-Founders of STI Technologies, which helped drug companies distribute samples efficiently. It was sold to the American multinational QuintilesIMS in February 2017, reportedly for $200 million.
His new startup specializes in “medication adherence”, meaning it has developed a digital solution that helps patients